Sugarbaker PH (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care. Cancer Treat Rev 48:42–49. https://doi.org/10.1016/j.ctrv.2016.06.007

Article  PubMed  Google Scholar 

Moran BJ (2006) Decision-making and technical factors account for the learning curve in complex surgery. J Public Health (Oxf) 28(4):375–378. https://doi.org/10.1093/pubmed/fdl048

Article  CAS  PubMed  Google Scholar 

Kepenekian V, Bhatt A, Péron J, Alyami M, Benzerdjeb N, Bakrin N, Falandry C, Passot G, Rousset P, Glehen O (2022) Advances in the management of peritoneal malignancies. Nat Rev Clin Oncol 19(11):698–718. https://doi.org/10.1038/s41571-022-00675-5

Article  PubMed  Google Scholar 

Miguez González J, Calaf Forn F, Pelegrí Martínez L, Lozano Arranz P, Oliveira Caiafa R, Català Forteza J, Palacio Arteaga LM, Losa Gaspà F, Ramos Bernadó I, Barrios Sánchez P, Ayuso Colella JR (2023) Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation. Insights Imaging 14(1):115. https://doi.org/10.1186/s13244-023-01417-6

Article  PubMed  PubMed Central  Google Scholar 

Bhatt A, Yonemura Y, Mehta S, Benzerdjeb N, Kammar P, Parikh L, Prabhu A, Mishra S, Shah M, Shaikh S, Kepenekian V, Bonnefoy I, Patel MD, Isaac S, Glehen O (2020) The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors. Ann Surg Oncol 27(8):2985–2996. https://doi.org/10.1245/s10434-020-08234-x

Article  PubMed  Google Scholar 

Mittal R, Chandramohan A, Moran B (2017) Pseudomyxoma peritonei: natural history and treatment. Int J Hyperth 33(5):511–519. https://doi.org/10.1080/02656736.2017.1310938

Article  Google Scholar 

Sugarbaker PH (2017) “Total mesenteric peritonectomy for peritoneal metastases” (with video) by Jean-Baptiste Cazauran et al. Ann Surg Oncol 24(13):3799–3800. https://doi.org/10.1245/s10434-017-6100-3

Article  PubMed  Google Scholar 

Govaerts K, Lurvink RJ, De Hingh IHJT, Van der Speeten K, Villeneuve L, Kusamura S, Kepenekian V, Deraco M, Glehen O, Moran BJ, PSOGI (2021) Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol 47(1):11–35. https://doi.org/10.1016/j.ejso.2020.02.012

Article  CAS  Google Scholar 

Kusamura S, Kepenekian V, Villeneuve L, Lurvink RJ, Govaerts K, De Hingh IHJT, Moran BJ, Van der Speeten K, Deraco M, Glehen O, PSOGI, (2021) Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol 47(1):36–59. https://doi.org/10.1016/j.ejso.2020.02.011

Article  CAS  Google Scholar 

Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C, González-Martin A, Gourley C, Leary A, Lorusso D, Banerjee S, Chiva L, Cibula D, Colombo N, Croce S, Eriksson AG, Falandry C, Fischerova D, Harter P, Joly F, … Fagotti A (2024) ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol: Off J Eur Soc Med Oncol 35(3):248–266. https://doi.org/10.1016/j.annonc.2023.11.015

Low RN, Barone RM, Rousset P (2021) Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: history, clinical applications, and implementation. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 47(1):65–74. https://doi.org/10.1016/j.ejso.2019.02.030

Article  Google Scholar 

Chia CS, Wong LCK, Hennedige TP, Ong WS, Zhu HY, Tan GHC, Kwek JW, Seo CJ, Wong JSM, Ong CJ, Thng CH, Soo KC, Teo MCC (2022) Prospective comparison of the performance of MRI versus CT in the detection and evaluation of peritoneal surface malignancies. Cancers 14(13):3179. https://doi.org/10.3390/cancers14133179

Article  PubMed  PubMed Central  Google Scholar 

Chang MC, Chen JH, Liang JA, Huang WS, Cheng KY, Kao CH (2013) PET or PET/CT for detection of peritoneal carcinomatosis: a meta-analysis. Clin Nucl Med 38(8):623–629. https://doi.org/10.1097/RLU.0b013e318299609f

Article  PubMed  Google Scholar 

Mohkam K, Passot G, Cotte E, Bakrin N, Gilly FN, Ledochowski S, Bernard L, Valette PJ, Glehen O, Rousset P (2016) Resectability of peritoneal carcinomatosis: learnings from a prospective cohort of 533 consecutive patients selected for cytoreductive surgery. Ann Surg Oncol 23(4):1261–1270. https://doi.org/10.1245/s10434-015-5005-2

Article  PubMed  Google Scholar 

Chicago Consensus Working Group (2020) The Chicago consensus on peritoneal surface malignancies: standards. Cancer 126(11):2516–2524. https://doi.org/10.1002/cncr.32825

Article  Google Scholar 

Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, Dartigues P et al (2014) Description du réseau et rôle des pathologistes [The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists]. Ann Pathol 34(1):4

Article  PubMed  Google Scholar 

Bhatt A, Mishra S, Parikh L, Sheth S, Gorur I (2020) Essentials for pathological evaluation of peritoneal surface malignancies and synoptic reporting of cytoreductive surgery specimens-a review and evidence-based guide. Indian J Surg Oncol 11(1):101–126. https://doi.org/10.1007/s13193-019-00897-7

Article  PubMed  Google Scholar 

Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374. https://doi.org/10.1007/978-1-4613-1247-5_23

Article  CAS  PubMed  Google Scholar 

Beaujard AC, Glehen O, Caillot JL, Francois Y, Bienvenu J, Panteix G, Garbit F, Grandclément E, Vignal J, Gilly FN (2000) Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88(11):2512–2519. https://doi.org/10.1002/1097-0142(20000601)88:11%3c2512::aid-cncr12%3e3.0.co;2-j

Article  CAS  PubMed  Google Scholar 

Yonemura Y, Bandou E, Kawamura T, Endou Y, Sasaki T (2006) Quantitative prognostic indicators of peritoneal dissemination of gastric cancer. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol 32(6):602–606. https://doi.org/10.1016/j.ejso.2006.03.003

Article  CAS  Google Scholar 

Witkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW, van Coevorden F, Zoetmulder FA (2001) Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer (Oxford, England : 1990) 37(8):979–984. https://doi.org/10.1016/s0959-8049(01)00058-2

Article  CAS  Google Scholar 

Petrillo M, Vizzielli G, Fanfani F, Gallotta V, Cosentino F, Chiantera V, Legge F, Carbone V, Scambia G, Fagotti A (2015) Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept. Gynecol Oncol 139(1):5–9. https://doi.org/10.1016/j.ygyno.2015.07.095

Article  CAS  PubMed  Google Scholar 

Kim NY, Jung DC, Lee JY, Han KH, Oh YT (2021) CT-based Fagotti scoring system for non-invasive prediction of cytoreduction surgery outcome in patients with advanced ovarian cancer. Korean J Radiol 22(9):1481–1489. https://doi.org/10.3348/kjr.2020.1477

Article  PubMed  PubMed Central  Google Scholar 

Jónsdóttir B, Lomnytska M, Poromaa IS, Silins I, Stålberg K (2021) The peritoneal cancer index is a strong predictor of incomplete cytoreductive surgery in ovarian cancer. Ann Surg Oncol 28(1):244–251. https://doi.org/10.1245/s10434-020-08649-6

Article  PubMed  Google Scholar 

Bhatt A, Rousset P, Benzerdjeb N, Kammar P, Mehta S, Parikh L, Goswami G, Shaikh S, Kepenekian V, Passot G, Glehen O (2020) Prospective correlation of the radiological, surgical and pathological findings in patients undergoing cytoreductive surgery for colorectal peritoneal metastases: implications for the preoperative estimation of the peritoneal cancer index. Color Dis: Off J Assoc Coloproctol Great Britain Ireland 22(12):2123–2132. https://doi.org/10.1111/codi.15368

Article  CAS  Google Scholar 

Ji ZH, Yu Y, Liu G, Zhang YB, An SL, Li B, Li XB, Yan GJ, Li Y (2021) Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: a single-center retrospective analysis of 125 patients. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 47(6):1411–1419. https://doi.org/10.1016/j.ejso.2020.11.139

Article  Google Scholar 

Chandramohan A, Thrower A, Smith SA, Shah N, Moran B (2017) “PAUSE”: a method for communicating radiological extent of peritoneal malignancy. Clin Radiol 72(11):972–980. https://doi.org/10.1016/j.crad.2017.07.005

Article  CAS  PubMed  Google Scholar 

Villeneuve L, Thivolet A, Bakrin N, Mohamed F, Isaac S, Valette PJ, Glehen O, Rousset P, BIG-RENAPE and RENAPE Working Groups (2016) A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol 42(6):877–882

Article  CAS  Google Scholar 

Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16(2):327–333. https://doi.org/10.1245/s10434-008-0234-2

Article  PubMed